A Hepatitis C Viral Kinetic Model that Allows for Time-Varying Drug Effectiveness (original) (raw)
Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α-2b
Alan Perelson
Journal of Viral Hepatitis, 2008
View PDFchevron_right
Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b
Kimberly Powers
Seminars in liver disease, 2003
View PDFchevron_right
Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase
Barbara Coco
Antiviral therapy, 2003
View PDFchevron_right
Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacy
Alan Perelson
Journal of Theoretical Biology, 2007
View PDFchevron_right
Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells
Veronica Romagnoli, Barbara Coco
Clinical Pharmacology and Therapeutics, 2008
View PDFchevron_right
A perspective on modelling hepatitis C virus infection
Alan Perelson
Journal of Viral Hepatitis, 2010
View PDFchevron_right
Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling
Alan Perelson
Critical reviews in immunology, 2010
View PDFchevron_right
A comprehensive hepatitis C viral kinetic model explaining cure
Joseph Grippo
Clinical pharmacology and therapeutics, 2010
View PDFchevron_right
Modelling Hepatitis C virus Kinetics: The Relationship between the Infected Cell Loss rate and the Final Slope of Viral Decay
Alan Perelson
2009
View PDFchevron_right
A hepatitis C virus infection model with time-varying drug effectiveness: solution and analysis
Alan Perelson
PLoS computational biology, 2014
View PDFchevron_right
Modeling the dynamics of Hepatitis C Virus with combined antiviral drug therapy: Interferon and Ribavirin
Sandip Banerjee
Arxiv preprint arXiv:1105.3669, 2011
View PDFchevron_right
Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
Corinne Castelnau
Journal of Viral Hepatitis, 2006
View PDFchevron_right
Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using a Mathematical Model
Carlos Stalgis
2000
View PDFchevron_right
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
R. WejstÅl
Journal of Viral Hepatitis, 2012
View PDFchevron_right
Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C Dinámica viral y predicción …
Jose Aguilar Reina
Rev. esp. enferm. dig, 2009
View PDFchevron_right
Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon
Bruno Sainz
Journal of Virology, 2009
View PDFchevron_right
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a
Markus Reiser
Gastroenterology, 2001
View PDFchevron_right
Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta
Osamu Yokosuka
Journal of Hepatology, 2000
View PDFchevron_right
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients
M. Lapalus
Antimicrobial agents and chemotherapy, 2014
View PDFchevron_right
A pharmacokinetic-viral kinetic model describes the effect of alisporivir as monotherapy or in combination with peg-IFN on hepatitis C virologic response
Huyen Tram Nguyen
Clinical pharmacology and therapeutics, 2014
View PDFchevron_right
A Mathematical Model of Hepatitis C Virus Dynamics in Patients With High Baseline Viral Loads or Advanced Liver Disease
Harel Dahari
Gastroenterology, 2009
View PDFchevron_right
A model to predict long-term sustained response to interferon therapy in chronic hepatitis C
Franco Noventa
Journal of Viral Hepatitis, 1997
View PDFchevron_right
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patients
Hacène Khiri, Denis Ouzan
Comparative hepatology, 2005
View PDFchevron_right
Estimating drug efficacy and viral dynamic parameters: HIV and HCV
Alan Perelson
Statistics in Medicine, 2008
View PDFchevron_right
Variables that influence response to different interferon schedules in chronic hepatitis C and predictive models
P. Pontisso
Journal of Viral Hepatitis, 1997
View PDFchevron_right
Hepatitis C viral kinetics in special populations
Alan Perelson
Current Hepatitis Reports, 2008
View PDFchevron_right
Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients
Kenneth Sherman
Gastroenterology, 2005
View PDFchevron_right